Advanced Oxygen Technologies, Inc.

Advanced Oxygen Technologies, Inc.

AOXY
Advanced Oxygen Technologies, Inc.US flagOther OTC
0.10
USD
-0.01
- -
322,709.00Market Cap
Advanced Oxygen Technologies, Inc.
AOXY
(Other OTC)

Recent

price

0.10

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
0.02
0.02
0.03
0.03
0.02
0.02
0.02
0.02
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Revenue per Share
0.01
0.03
-0.01
0.01
-0.03
0.01
- -
- -
- -
- -
-0.03
- -
0.02
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
-0.04
- -
-0.01
0.01
0.02
0.01
0.01
0.01
0.03
0.01
0.01
0.01
0.02
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-8.69
-8.83
-8.84
-8.83
-8.85
-9.04
-9.04
-9.04
-9.03
-9.03
-6.79
-6.31
-6.3
-6.3
-6.29
-6.29
-6.29
Book Value per Share
0.07
0.11
0.1
0.11
0.08
0.11
0.12
0.13
0.13
0.13
0.1
0.11
0.1
0.11
0.1
0.13
0.12
Tangible Book Value per Share
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
51.4
-121.76
69.77
55.69
-136.11
60.66
65.93
42.41
51.46
49.92
-213.21
40.26
33.1
28.43
33.94
31.7
30.19
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
31.59
- -
- -
29.41
99.9
49.13
45.9
- -
58.93
12.38
78.23
62.27
70.7
75.29
Effective Tax Rate (%)
38.84
165.07
-33.96
54.44
-144.82
47.08
30.42
0.03
18.75
21.12
-238.92
13.87
144.23
5.76
13.07
9.52
7.46
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
5.19
-10.94
- -
4.63
- -
- -
2.88
- -
1.81
1.86
- -
1.25
2.1
0.46
1
0.69
0.56
Return on Invested Capital (%)
-0.12
-0.37
- -
-0.18
- -
- -
-0.08
- -
-0.05
-0.05
- -
-0.03
-0.28
-0.01
-0.03
-0.02
-0.02
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
3
3
3
Market Capitalization
- -
- -
- -

Working Capital

FRC

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.08%
6.85%
21.55%
Free Cash Flow
-75.68%
19.58%
-10.42%
Net Income, GAAP
8,205.25%
161.93%
-25.63%
Sales/Revenue/Turnover
1.39%
0.24%
2.04%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Advanced Oxygen Technologies, Inc. (AOXY) develops and commercializes advanced oxygen-related technologies for medical, industrial, and environmental applications. The company offers portable oxygen concentrators, oxygen generation systems, and related accessories, including models such as the AOT OM-1 and OM-2 portable units designed for therapeutic use; stationary oxygen concentrators for home and clinical settings; and industrial oxygen solutions for applications like aquaculture, wastewater treatment, and ozone generation. These products utilize proprietary pressure swing adsorption (PSA) technology to produce high-purity oxygen efficiently, targeting healthcare providers, patients with respiratory conditions, industrial manufacturers, and environmental service companies primarily in Canada and the United States. Founded in 2019 and headquartered in Richmond, British Columbia, Canada, the company operates through its primary website at www.aoxy-ca.com and focuses on North American markets with potential expansion into Asia-Pacific regions. In late 2024, Advanced Oxygen Technologies announced a strategic partnership with a leading Canadian healthcare distributor to expand distribution of its OM-series portable concentrators across Western Canada, enhancing market penetration. Additionally, in Q3 2025, the company completed a $2.5 million private placement funding round led by existing institutional investors to support R&D for next-generation lightweight concentrators and production scaling; it also launched the AOT Pro Industrial series for aquaculture oxygen enrichment, marking entry into the commercial farming segment.

Company News

APIChat
  • Critical Contrast: Derwent Valley (OTCMKTS:DWVYF) vs. Advanced Oxygen Technologies (OTCMKTS:AOXY)